Magnitude Biosciences Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 19

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.76M

  • Investors
  • 10

Magnitude Biosciences General Information

Description

Operator of a patented in vivo testing platform designed to accelerate drug and product development through rapid, cost-effective data generation using C. elegans. The company offers high-throughput, whole-organism insights into efficacy, toxicity, and mechanisms of action, enabling pharmaceutical, biotech, and nutraceutical developers to reduce preclinical timelines and costs with an ethical alternative to mammalian models.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • NETPark Plexus
  • Thomas Wright Way
  • Sedgefield TS21 3FD
  • England, United Kingdom
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Vertical(s)
Corporate Office
  • NETPark Plexus
  • Thomas Wright Way
  • Sedgefield TS21 3FD
  • England, United Kingdom

Magnitude Biosciences Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Magnitude Biosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC 15-Sep-2026 $1.76M Completed Generating Revenue
9. Later Stage VC 30-Mar-2025 Completed Generating Revenue
8. Grant 01-Apr-2023 Completed Generating Revenue
7. Seed Round 14-Nov-2022 Completed Generating Revenue
6. Seed Round 19-Aug-2020 Completed Generating Revenue
5. Seed Round 02-Dec-2019 Completed Generating Revenue
4. Accelerator/Incubator 01-Jan-2019 Completed Generating Revenue
3. Grant 01-Oct-2018 Completed Startup
2. Seed Round 20-Sep-2018 $195K $195K Completed Startup
1. University Spin-Out 20-Sep-2018 Completed Startup
To view Magnitude Biosciences’s complete valuation and funding history, request access »

Magnitude Biosciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
A Ordinary
Ordinary
A Ordinary
A Ordinary
A Ordinary 56,400 $0.001289 $5.14 $5.14 1x $5.14 13.35%
A Ordinary 37,600 $0.001289 $5.14 $5.14 1x $5.14 8.9%
To view Magnitude Biosciences’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Magnitude Biosciences Patents

Magnitude Biosciences Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202418752-D0 Sample holder, and systems and methods for imaging and illuminating samples in a sample holder Pending 19-Dec-2024
GB-2703759-A Sample holder, and systems and methods for imaging and illuminating samples in a sample holder Pending 19-Dec-2024
WO-2026132803-A1 Sample holder, and systems and methods for imaging and illuminating samples in a sample holder Pending 19-Dec-2024
GB-2592149-B Method and apparatus for tracking nematode worms Active 18-Oct-2018
US-11756214-B2 Method and apparatus for tracking nematode worms Active 18-Oct-2018 G06T7/254
To view Magnitude Biosciences’s complete patent history, request access »

Magnitude Biosciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Magnitude Biosciences Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds
British Business Bank Lender/Debt Provider Minority
Business Durham Corporation Minority
Maven Capital Partners UK PE/Buyout Minority
Innovate UK Government
Government of UK Government Minority
You’re viewing 5 of 10 investors. Get the full list »

Magnitude Biosciences Acquisitions (1)

Magnitude Biosciences’s most recent deal was a Merger/Acquisition with Invermis. The deal was made on 15-May-2020.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Invermis 15-May-2020 Merger/Acquisition Biotechnology
To view Magnitude Biosciences’s complete acquisitions history, request access »

Magnitude Biosciences FAQs

  • When was Magnitude Biosciences founded?

    Magnitude Biosciences was founded in 2018.

  • Where is Magnitude Biosciences headquartered?

    Magnitude Biosciences is headquartered in Sedgefield, United Kingdom.

  • What is the size of Magnitude Biosciences?

    Magnitude Biosciences has 19 total employees.

  • What industry is Magnitude Biosciences in?

    Magnitude Biosciences’s primary industry is Drug Discovery.

  • Is Magnitude Biosciences a private or public company?

    Magnitude Biosciences is a Private company.

  • What is Magnitude Biosciences’s current revenue?

    The current revenue for Magnitude Biosciences is .

  • How much funding has Magnitude Biosciences raised over time?

    Magnitude Biosciences has raised $4.61M.

  • Who are Magnitude Biosciences’s investors?

    British Business Bank, Business Durham, Maven Capital Partners UK, Innovate UK, and Government of UK are 5 of 10 investors who have invested in Magnitude Biosciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process